OgilvyHealthPR wins Boehringer Ingelheim anti-clot drug brief

Pharma firm Boehringer Ingelheim has brought in OgilvyHealthPR as the global comms agency for its Pradaxa drug, which prevents blood clotting.

Pradaxa manufacturer: Boehringer Ingelheim's HQ
Pradaxa manufacturer: Boehringer Ingelheim's HQ

OgilvyHealthPR won the account following a competitive pitch and replaces Chandler Chicco Companies' medical education division Litmus. Pradaxa is an oral anticoagulant, used to prevent and treat acute and chronic thromboembolic disease.

OgilvyHealthPR will work with sister company Ogilvy Healthworld Digital to dev­elop and implement an integrated comms programme. Ogilvy Healthworld Digital is headed up by managing partners Caroline Howe and David Davenport-Firth.

Pradaxa is currently used in more than 50 countries for primary prevention of venous thromboembolic occurrences in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery. It is also being investigated for the prevention of stroke in pat­ients with atrial fibrillation (abnormal heart rhythm).

The account will be led by OgilvyHealthPR business unit head Deanne Wallace, who is based in London.
OgilvyHealthPR already works on other global acc­ounts with Boehringer Ingelheim, including its diabetes portfolio.

Additionally, the agency has bolstered its senior team with the appointment of Ben Fisher as associate director. Fisher has ten years' experience in healthcare comms and joins the agency from Porter Novelli where he was an account director.

He will head up the Boeh­ringer Ingelheim diabetes portfolio, in addition to focusing on new business.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.